Tempest Therapeutics Inc. (TPST)
NASDAQ: TPST
· Real-Time Price · USD
10.58
1.10 (11.60%)
At close: Aug 15, 2025, 3:59 PM
10.72
1.32%
After-hours: Aug 15, 2025, 07:28 PM EDT
Tempest Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -43.1M | -44.8M | -41.84M | -35.52M | -31.75M | -29.76M | -29.49M | -31.11M | -33.27M | -34.85M | -35.71M | -34.38M | -33.55M | -31.44M | -28.3M | -24.84M | -22.16M | -20.34M |
Depreciation & Amortization | 281K | 369K | 389K | 425K | 416K | 344K | 381K | 513K | 626K | 655K | 638K | 523K | 429K | 404K | 374K | 356K | 330K | 323K |
Stock-Based Compensation | 5.15M | 5.37M | 5.3M | 5.07M | 4.3M | 3.42M | 2.55M | 1.88M | 1.75M | 1.68M | 1.56M | 1.41M | 1.27M | 1.31M | 1.1M | 959K | 754K | 570K |
Other Working Capital | -3.71M | 2.72M | 8K | -1.27M | -652K | -2.06M | -2.41M | -922K | -347K | -1.76M | 867K | -194K | 7K | 1.47M | -404K | -1.2M | -530K | 1.91M |
Other Non-Cash Items | 1.23M | 1.33M | 1.51M | 3.23M | 3.4M | 3.44M | 3.44M | 1.86M | 1.67M | 1.68M | 1.57M | 1.5M | 1.76M | 1.72M | 1.48M | 1.19M | 769K | -76K |
Deferred Income Tax | n/a | n/a | n/a | -1.56M | -1.56M | -1.56M | -1.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -355K | 3.85M | 1.61M | -705K | -163K | -2.13M | -2.68M | -804K | -1.02M | -1.43M | 868K | -1.62M | -5.21M | 1.25M | -613K | 96K | 5.23M | -332K |
Operating Cash Flow | -36.8M | -33.88M | -33.03M | -29.05M | -25.36M | -26.24M | -27.36M | -27.66M | -30.25M | -32.27M | -31.07M | -32.58M | -35.3M | -26.75M | -25.96M | -22.25M | -15.08M | -19.85M |
Capital Expenditures | -18K | -267K | -435K | -439K | -424K | -292K | -170K | -519K | -627K | -605K | -562K | -233K | -149K | -124K | -135K | -113K | -97K | -52K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 38K | 38K | 38K | 38K | n/a | n/a |
Investing Cash Flow | -18K | -267K | -435K | -439K | -424K | -292K | -170K | -519K | -627K | -605K | -562K | -233K | -111K | -86K | -97K | -75K | -97K | -52K |
Debt Repayment | -10.82M | -6.6M | -4.4M | -2.2M | n/a | n/a | n/a | -4.74M | -4.74M | -4.74M | -4.74M | n/a | n/a | n/a | 15M | 15M | 15M | 15M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 111K | 111K | 308K | 308K | 197K | 197K | n/a | n/a | n/a | 7.28M | 7.28M | 7.32M | 7.02M | 10.69M | 10.64M | 10.63M | 10.94M | -15K |
Financial Cash Flow | 19.97M | 23.33M | 24.5M | 40.9M | 39.38M | 36.01M | 35.6M | -3.47M | -3.14M | 10.04M | 11.4M | 16.12M | 18.94M | 45.52M | 59.06M | 59.1M | 55.95M | 14.91M |
Net Cash Flow | -17.2M | -11.17M | -9.31M | 11M | 13.54M | 9.42M | 8.02M | -31.65M | -34.02M | -22.83M | -20.23M | -16.6M | -16.47M | 18.68M | 33.01M | 36.69M | 40.77M | -4.92M |
Free Cash Flow | -20.35M | -34.14M | -33.46M | -29.49M | -25.78M | -26.53M | -27.53M | -28.18M | -30.87M | -32.87M | -31.63M | -32.81M | -35.44M | -26.88M | -26.09M | -22.36M | -15.18M | -19.9M |